Busch MP - Search Results

1

Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.

Jones JM, Stone M, Sulaeman H, Fink RV, Dave H, Levy ME, Di Germanio C, Green V, Notari E, Saa P, Biggerstaff BJ, Strauss D, Kessler D, Vassallo R, Reik R, Rossmann S, Destree M, Nguyen KA, Sayers M, Lough C, Bougie DW, Ritter M, Latoni G, Weales B, Sime S, Gorlin J, Brown NE, Gould CV, Berney K, Benoit TJ, Miller MJ, Freeman D, Kartik D, Fry AM, Azziz-Baumgartner E, Hall AJ, MacNeil A, Gundlapalli AV, Basavaraju SV, Gerber SI, Patton ME, Custer B, Williamson P, Simmons G, Thornburg NJ, Kleinman S, Stramer SL, Opsomer J, Busch MP. Jones JM, et al. Among authors: busch mp. JAMA. 2021 Oct 12;326(14):1400-1409. doi: 10.1001/jama.2021.15161. JAMA. 2021. PMID: 34473201 Free PMC article.

2

Post-transfusion hepatitis C virus infection.

Kleinman S, Busch M, Holland P. Kleinman S, et al. N Engl J Med. 1992 Nov 26;327(22):1601-2. doi: 10.1056/NEJM199211263272216. N Engl J Med. 1992. PMID: 1279422 No abstract available.

3

Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay.

Kleinman S, Alter H, Busch M, Holland P, Tegtmeier G, Nelles M, Lee S, Page E, Wilber J, Polito A. Kleinman S, et al. Transfusion. 1992 Nov-Dec;32(9):805-13. doi: 10.1046/j.1537-2995.1992.32993110750.x. Transfusion. 1992. PMID: 1471243

4

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.

Petersen LR, Satten GA, Dodd R, Busch M, Kleinman S, Grindon A, Lenes B. Petersen LR, et al. Transfusion. 1994 Apr;34(4):283-9. doi: 10.1046/j.1537-2995.1994.34494233574.x. Transfusion. 1994. PMID: 8178324

5

Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.

Kleinman SH, Kaplan JE, Khabbaz RF, Calabro MA, Thomson R, Busch M. Kleinman SH, et al. J Clin Microbiol. 1994 Mar;32(3):603-7. doi: 10.1128/jcm.32.3.603-607.1994. J Clin Microbiol. 1994. PMID: 8195365 Free PMC article.

6

Oversight and monitoring of blood safety in the United States.

Busch M, Chamberland M, Epstein J, Kleinman S, Khabbaz R, Nemo G. Busch M, et al. Vox Sang. 1999;77(2):67-76. doi: 10.1159/000031079. Vox Sang. 1999. PMID: 10516550 Review.

7

HIV seroconverting donors delay their return: screening test implications.

Schreiber GB, Glynn SA, Satten GA, Kong F, Wright D, Busch MP, Tu Y, Kleinman SH; Retrovirus Epidemiology Donor Study. Schreiber GB, et al. Among authors: busch mp. Transfusion. 2002 Apr;42(4):414-21. doi: 10.1046/j.1525-1438.2002.00084.x. Transfusion. 2002. PMID: 12076287

8

Impact of changes in viral marker screening assays.

Sharma UK, Stramer SL, Wright DJ, Glynn SA, Hermansen S, Schreiber GB, Kleinman SH, Busch MP; Retrovirus Epidemiology Donor Study. Sharma UK, et al. Among authors: busch mp. Transfusion. 2003 Feb;43(2):202-14. doi: 10.1046/j.1537-2995.2003.00291.x. Transfusion. 2003. PMID: 12559016

9

Current and emerging infectious risks of blood transfusions.

Busch MP, Kleinman SH, Nemo GJ. Busch MP, et al. JAMA. 2003 Feb 26;289(8):959-62. doi: 10.1001/jama.289.8.959. JAMA. 2003. PMID: 12597733 No abstract available.

10

Effect of a national disaster on blood supply and safety: the September 11 experience.

Glynn SA, Busch MP, Schreiber GB, Murphy EL, Wright DJ, Tu Y, Kleinman SH; NHLBI REDS Study Group. Glynn SA, et al. Among authors: busch mp. JAMA. 2003 May 7;289(17):2246-53. doi: 10.1001/jama.289.17.2246. JAMA. 2003. PMID: 12734136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

700 results

Search Page